Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Tenet Healthcare's (THC) aim to boost USPI's network through continuous buyouts is positioning the company well for growth.

Tenet Healthcare (THC) Gains 42.1% YTD: More Room to Run?

Darling Ingredients

Viking Therapeutics

Chemed

Lantheus Holdings

Merus

Carrols Restaurant Group

Stock screeners can help investors identify stocks to buy based on a variety of criteria. In fact, one helpful predictor of stock price growth can be found with analyst ratings.

7 Stocks That Wall Street Analysts Are Loving in May

Tenet Healthcare is a diversified healthcare provider. In the last quarter, the company reported one more hospital as compared to that in 2022. As a result, the KPIs improved.

Tenet Healthcare: More M&A And Recruitment Efforts Could Imply Undervaluation

Health Care Facilities industry companies have performed relatively poorly since late last year amid the broad market rally. With stronger volumes and reimbursement trends in Q1 and in April, Tenet Healthcare remains modestly undervalued.

Tenet Healthcare: Shares Undervalued After A Q1 Beat And Raise

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of all $756 million outstanding of its 4.625% senior secured first lien notes due July 2024 (the “July 2024 Notes”), which were issued pursuant to the Indenture, dated as of November 6, 2001, by and between Tenet and The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York (the “Base Indenture”), as supplemented by the Twenty-Ninth Supplemental Indenture, dated.

Tenet Calls for Full Redemption of 4.625% Senior Secured First Lien Notes due 2024

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.350 billion in aggregate principal amount of senior secured first lien notes due on May 15, 2031, which will bear interest at a rate of 6.750% per annum (the “notes”). Completion of the notes offering is expected to occur on May 16, 2023, and is subject to, among other things, customary closing conditions. Tenet.

Tenet Announces Pricing of its $1.350 Billion Private Offering of Senior Secured Notes

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.350 billion in aggregate principal amount of new senior secured first lien notes maturing in 2031 (the “notes”). Completion of the notes offering is subject to, among other things, pricing and customary closing conditions. Tenet intends to use the net proceeds from the sale of the notes, after payment of fees and expenses, to finance, together with cash on hand, the redemption of.

Tenet Announces $1.350 Billion Private Offering of Senior Secured Notes

Tenet Healthcare's (THC) first-quarter 2023 results gain on increased patient volumes. Management presently expects adjusted EPS within $4.92-$6.09 in 2023, up from the prior view of $4.68-$5.85.

Tenet Healthcare's (THC) Q1 Earnings Beat, Shares Up 3.9%

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2023 Health Care Conference in Las Vegas, NV, on Tuesday, May 9, 2023, beginning at 9:20 a.m. Pacific time (12:20 p.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare service.

Tenet to Participate in BofA Securities 2023 Health Care Conference

Tenet Healthcare Corporation (THC) Q1 2023 Earnings Call Transcript.

Tenet Healthcare Corporation (THC) Q1 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Tenet (THC) Q1 Earnings: A Look at Key Metrics

Tenet Healthcare (THC) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.93 per share a year ago.

Tenet Healthcare (THC) Q1 Earnings and Revenues Beat Estimates

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2023. "We delivered a positive start to the year across the organization and in particular, strong growth in revenues, volumes, and Adjusted EBITDA in our ambulatory care segment," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "Our commitment to expanding access to high-quality, specialty care and maintaining our disciplined approach to managing oper.

Tenet Reports First Quarter 2023 Results; Raises 2023 Outlook

Acadia Healthcare

HCA Healthcare

Universal Health Services

Easing staffing challenges and technological adoption are aiding the margins of the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Acadia (ACHC) and Tenet Healthcare (THC) are poised to gain from improving volumes.

4 Stocks in Focus as Hospital Industry Witnesses Improvement

Acadia Healthcare (ACHC) and Tenet Healthcare (THC) are poised to grow in the promising hospital space. We try to find out which stock fares better via comparative evaluation.

ACHC or THC: Which Hospital Stock is Better-Positioned?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2023 results before the market opens on Tuesday, April 25, 2023, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors.

Tenet to Report its First Quarter 2023 Results on April 25th

Tenet Healthcare's (THC) focus on boosting USPI's network is positioning the company for expedited growth.

Tenet Healthcare (THC) Jumps 14.9% YTD: More Growth Ahead?

CONSOL Energy

Teck Resources

David Einhorn's Greenlight Capital returned 36.6% last year thanks to a combination of successful short bets and a portfolio of value-oriented stocks.

David Einhorn's hedge fund crushed the S&P 500 last year. These are the 3 stocks he's counting on for continued outperformance.

Greenlight Capital's David Einhorn is far from bullish, but he sees massive opportunity in a few value names the market has forgotten about.

David Einhorn Sees 'Increasingly Difficult' Environment For Stocks, But He's Betting On These 3 'Ridiculously Inexpensive' Names - Tenet Healthcare (NYSE:THC)

Tenet Healthcare, a $25 billion healthcare facilities owner & operator, is a Wall Street darling with an exceptionally large involvement of hedge fund investors. The company looks like a reasonable investment, but we dislike multiple things: the high effective leverage, leakage of value to minorities, and the recent run-up in its stock price.

Tenet Healthcare Is A Wall Street Darling, But Not Ours

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2023, beginning at 9:30 a.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days.

Tenet to Participate in Barclays Global Healthcare Conference

Funko

Intel

Rivian Automotive

Bilibili

Kyndryl Holdings

News Corp

David Einhorn's Greenlight Capital Inc. cut its stake in Intel Corp. and opened new positions in Tenet Healthcare Corp. and bobblehead maker Funko Inc., among other investment decisions in the fourth quarter, according to a filing late Tuesday.

Greenlight sells off Intel and Rivian, adds Tenet, Funko

Tenet Healthcare's (THC) bottom line deteriorates due to higher operating expenses, partially offset by an improving Ambulatory Care segment.

Tenet (THC) Q4 Earnings Beat on Ambulatory Care Strength

Tenet Healthcare Corporation (NYSE:THC ) Q4 2022 Earnings Conference Call February 9, 2023 10:00 AM ET Company Participants Will McDowell - Vice President of Investor Relations Saum Sutaria - Chief Executive Officer Dan Cancelmi - Executive Vice President & Chief Financial Officer Conference Call Participants Kevin Fischbeck - Bank of America Jamie Perse - Goldman Sachs Justin Lake - Wolfe Research Ann Hynes - Mizuho A.J. Rice - Credit Suisse John Ransom - Raymond James Josh Raskin - Nephron Research Steven Valiquette - Barclays Whit Mayo - SVB Securities Andrew Mok - UBS Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Stephen Baxter - Wells Fargo Operator Good morning.

Tenet Healthcare Corporation (THC) Q4 2022 Earnings Call Transcript

Tenet (THC) delivered earnings and revenue surprises of 54.33% and 1.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Tenet Healthcare Stock (THC)